3/10/2024

Dicyclomine Oral Presentations

Products Affected - Description

- Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 100 count, NDC 00054-0748-25
- Dicyclomine hydrochloride capsule, Hikma, 10 mg, bottle, 1000 count, NDC 00054-0748-31
- Dicyclomine hydrochloride solution, Hikma, 10 mg/5 mL, 473 mL bottle, NDC 00054-0622-63
- Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 100 count, NDC 00143-1227-01
- Dicyclomine hydrochloride tablet, Hikma, 20 mg, bottle, 1000 count, NDC 00143-1227-10
- Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 100 count, NDC 00378-1610-01 - discontinued
- Dicyclomine hydrochloride capsule, Mylan (Viatris), 10 mg, bottle, 500 count, NDC 00378-1610-05 - discontinued
- Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 100 count, NDC 00378-1620-01 - discontinued
- Dicyclomine hydrochloride tablet, Mylan (Viatris), 20 mg, bottle, 500 count, NDC 00378-1620-05 - discontinued

Reason for the Shortage

- Hikma did not provide a reason for the shortage.
- Lannett has dicyclomine capsules and tablets available.
- Mylan discontinued the 20 mg tablets in June 2021. The 10 mg tablet presentations were discontinued in 2022.
- Par Pharmaceuticals has dicyclomine oral solution available.
- Teva did not provide a reason for the shortage.

Available Products

- Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-0586-01
- Dicyclomine hydrochloride capsule, Lannett, 10 mg, bottle, 1000 count, NDC 00527-0586-10
- Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 100 count, NDC 00527-1282-01
- Dicyclomine hydrochloride tablet, Lannett, 20 mg, bottle, 1000 count, NDC 00527-1282-10
- Dicyclomine hydrochloride solution, Par Pharmaceuticals, 10 mg/5 mL, 473 mL bottle, NDC 00603-1161-58
- Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 100 count, NDC 00591-0794-01
- Dicyclomine hydrochloride capsule, Teva, 10 mg, bottle, 1000 count, NDC 00591-0794-10
- Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-0795-01
- Dicyclomine hydrochloride tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-0795-10

Estimated Resupply Dates

- Hikma has all presentations on allocation.

Updated

Updated March 10, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created January 22, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.